Scinovex
article Open AccessTop 1% cited

Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine

Neuropsychopharmacology · 1996 · Vol. 14(2) · pp. 87–96
Frank P. BymasterDavid O. CalligaroJulie F. FalconeRichard D MarshNicholas MooreN.C. TyePhilip SeemanDavid T. Wong
Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and SignalingNeurotransmitter Receptor Influence on BehaviorOlanzapineClozapinePharmacologyAtypical antipsychoticHaloperidolAntipsychoticChemistry5-HT receptor5-HT1 receptorReceptor

MeSH terms

OlanzapineAnimalsBenzodiazepinesCattleCricetinaeHumansMaleMyocardiumPirenzepineRadioligand AssayReceptors, AdrenergicReceptors, DopamineReceptors, Histamine H1Receptors, MuscarinicReceptors, Serotonin
Citations
1,062
FWCI
19.34
field-weighted impact
References
55
Percentile
100%
vs. same field & year
Citations per year
References
Olanzapine versus Placebo and Haloperidol
Neuropsychopharmacology · 1996 · 785 citations
Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
Journal of Pharmacology and Experimental Therapeutics · 1990 · 612 citations
Dopamine receptor pharmacology
Trends in Pharmacological Sciences · 1994 · 960 citations
Clozapine for the Treatment-Resistant Schizophrenic
Archives of General Psychiatry · 1988 · 4,110 citations
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
Journal of Pharmacology and Experimental Therapeutics · 1989 · 1,350 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.